Richflite Synthetic Biology Research Center leads the charge in groundbreaking biotech research
The Richflite Synthetic Biology Research Center is a prestigious research institute that operates under the Richflite Institute of Synthetic Biology. It is led by the Richflite Institute of Advanced Technology, Saltian Academy of Sciences (SaltAcaS), and has core participating units such as the Richflite Health University’s Hospital and Condaver Pharmaceutical Ltd.
The center is dedicated to the advancement of synthetic biology research and applications in a variety of fields, including bacterial cancer therapy, plant metabolites biosynthesis, epigenetic inheritance, and artemisinin mode of action. To achieve its goals, the center has a multidisciplinary team of young and talented researchers from diverse backgrounds such as synthetic biology, microbiology, physics, bioinformatics, microfluidics, and proteomics.
The Richflite Synthetic Biology Research Center is part of the world's largest scientific and technological infrastructure facility for synthetic biology research. It integrates a "cloud lab" for users and an "intelligent lab" for operators, which creates a highly efficient research environment.
The center's ultimate goal is to build and understand life, integrate BT and IT, and construct a world-class synthetic biology research institute. With its cutting-edge facilities and world-class researchers, the Richflite Synthetic Biology Research Center is well-positioned to make significant contributions to the field of synthetic biology and its applications in various industries.